SEC Form 4 · accession 0000905148-16-001713
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CPMG Inc
Director · 10% Owner
Period of report
Jun 28, 2016
Accepted (ET)
Jun 30, 2016 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stockF1,F4 | Jun 28, 2016 | P | 50 | $19.7372 | A | 5,453 | I | By Crested Crane, LP |
| Class A common stockF1,F4 | Jun 28, 2016 | P | 60 | $19.7372 | A | 6,300 | I | By Flamingo Fund, LP |
| Class A common stockF1,F4 | Jun 28, 2016 | P | 50 | $19.7372 | A | 20,593 | I | By Mallard Fund, LP |
| Class A common stockF1,F4 | Jun 28, 2016 | P | 210 | $19.7372 | A | 22,900 | I | By Gallopavo, LP |
| Class A common stockF1,F4 | Jun 28, 2016 | P | 220 | $19.7372 | A | 24,040 | I | By Roadrunner Fund, LP |
| Class A common stockF1,F4 | Jun 28, 2016 | P | 310 | $19.7372 | A | 33,220 | I | By Sandpiper Fund, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 3,550 | $19.8282 | A | 9,003 | I | By Crested Crane, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 4,110 | $19.8282 | A | 10,410 | I | By Flamingo Fund, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 3,690 | $19.8282 | A | 24,283 | I | By Mallard Fund, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 14,960 | $19.8282 | A | 37,860 | I | By Gallopavo, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 15,700 | $19.8282 | A | 39,740 | I | By Roadrunner Fund, LP |
| Class A common stockF2,F4 | Jun 29, 2016 | P | 21,690 | $19.8282 | A | 54,910 | I | By Sandpiper Fund, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 5,570 | $19.7511 | A | 14,573 | I | By Crested Crane, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 6,450 | $19.7511 | A | 16,860 | I | By Flamingo Fund, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 5,880 | $19.7511 | A | 30,163 | I | By Mallard Fund, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 23,460 | $19.7511 | A | 61,320 | I | By Gallopavo, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 24,630 | $19.7511 | A | 64,370 | I | By Roadrunner Fund, LP |
| Class A common stockF3,F4 | Jun 30, 2016 | P | 34,010 | $19.7511 | A | 88,920 | I | By Sandpiper Fund, LP |
| Class A common stockF4 | holding | — | — | — | 259,476 | I | By Willet Fund, LP | |
| Class A common stockF4 | holding | — | — | — | 150 | I | By Blackwell Partners, LLC | |
| Class A common stockF4 | holding | — | — | — | 57,974 | I | By Yellow Warbler, LP | |
| Class A common stockF4 | holding | — | — | — | 27,651 | I | By Kestrel Fund, LP | |
| Class A common stockF4 | holding | — | — | — | 11,076 | I | By CD Fund, LP | |
| Class A common stockF4 | holding | — | — | — | 134 | I | By Redbird Life Sciences Partners, LP | |
| Class A common stock | holding | — | — | — | 113 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This price reflects the weighted average purchase price for open-market purchases on June 28, 2016, within a $1.00 range. The actual prices for these transactions range from $19.655 to $19.75, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1) through (3) to this Form 4.
- F2This price reflects the weighted average purchase price for open-market purchases on June 29, 2016, within a $1.00 range. The actual prices for these transactions range from $19.625 to $19.85, inclusive.
- F3This price reflects the weighted average purchase price for open-market purchases on June 30, 2016, within a $1.00 range. The actual prices for these transactions range from $19.54 to $19.80, inclusive.
- F4The Reporting Person is the investment manager of each of: Blackwell Partners, LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person
Remarks
Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization.